Skip to main content
SpringerLink
Log in

Prevention of Local Recurrence After Surgical Debulking of Nodal and Subcutaneous Melanoma Deposits by Hypofractionated Radiation

  • Original Article
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: Local recurrence (LR) after surgical debulking of nodal or subcutaneous melanoma deposits defeats the purpose of operation and may worsen prognosis if the procedure was performed for stage III disease. To decrease LR rates in this setting, we extended the previously described role of hypofractionated radiation for melanoma deposits of the neck to all situations where the patient was felt to be at high risk for postoperative relapse after resection of bulky disease.

Methods: Hypofractionated external beam radiation was administered in 6-Gy doses for 5 fractions (total dose 30 Gy, given over a median of 15 elapsed days) to 42 resected melanoma deposit sites in 41 patients.

Results: Stages of the 41 patients at the time of treatment were: 22 stage III and 19 stage IV. All patients had complete gross resection of disease at the radiation site before radiation. Mean time between operation and initiation of radiation was 4 weeks. The 42 sites of treatment included 27 neck, 9 axilla, 3 groin, and 3 subcutaneous deposits. There were no treatment-related deaths; side effects were minimal and self-limited. Transient erythema, desquamation, fibrosis, telangiectasias, and mucositis, parotiditis, and xerostomia (for head and neck radiation) were reported, but no patient required interruption of therapy for these events. Of the 42 treated sites, only 2 recurred in the treatment field (one neck, one axilla) during the mean follow-up time of 22.4 months, for a treatment failure rate of 4.8%. This represents improved local control compared with patients treated with surgery alone at our institution and with published recurrence rates.

Conclusions: The addition of hypofractionated radiation therapy after resection of nodal and subcutaneous melanoma deposits at a variety of sites is a rapid and well-tolerated method of providing excellent local control.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. O’Brien CJ, Coates AS, Petersen-Schaefer K, et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 1991;162:310–314.

    PubMed  Google Scholar 

  2. Soong SJ, Harrison RA, McCarthy WH, Urist MM, Balch CM. Factors affecting survival following local, regional, or distant recurrence from localized melanoma. J Surg Oncol 1998;67:228–233.

    CAS  PubMed  Google Scholar 

  3. Singletary SE, Shallenberger R, Guinee VF, McBride CM. Melanoma with metastases to regional axillary or inguinal lymph nodes: prognostic factors and results of surgical treatment in 714 patients. South Med J 1988;81:5–9.

    CAS  PubMed  Google Scholar 

  4. Byers RM. The role of modified neck dissection in the treatment of cutaneous melanoma of the head and neck. Arch Surg 1986;121:1338–1341.

    CAS  PubMed  Google Scholar 

  5. Strom EA, Ross MI. Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma: toxicity and local control. Ann Surg Oncol 1995;2:445–449.

    CAS  PubMed  Google Scholar 

  6. Ang KK, Byers RM, Peters LJ, et al. Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma. Arch Otolaryngol Head Neck Surg 1990;116:169–172.

    CAS  PubMed  Google Scholar 

  7. Calabro A, Singletary SE, Balch CM. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 1989;124:1051–1055.

    CAS  PubMed  Google Scholar 

  8. Harwood AR. Conventional fractionated radiotherapy for patients with lentigo maligna and lentigo maligna melanoma. Int J Radiat Oncol Biol Phys 1983;9:1019–1021.

    CAS  PubMed  Google Scholar 

  9. Barranco SC, Romsdahl MM, Humphrey RM. The radiation response of human melanoma cells grown in vitro. Cancer Res 1971;31:830–833.

    CAS  PubMed  Google Scholar 

  10. Habermalz HJ. Irradiation of malignant melanoma: experience in the past and present. Int J Radiat Oncol Biol Phys 1981;7:131–133.

    CAS  PubMed  Google Scholar 

  11. Trott KR. The optimal radiation dose per fraction for the treatment of malignant melanomas. Int J Radiat Oncol Biol Phys 1991;20:905–907.

    CAS  PubMed  Google Scholar 

  12. O’Brien CJ, Petersen-Schaefer K, Stevens G, et al. Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma. Head Neck 1997;19:589–594.

    PubMed  Google Scholar 

  13. Stevens G, Thompson JF, Firth I, O’Brien CJ, McCarthy WH, Quinn MJ. Locally advanced melanoma: results of postoperative hypofractionated radiation therapy. Cancer 2000;88:88–94.

    CAS  PubMed  Google Scholar 

  14. Zitsch RP, Roberts GD, Smith RB. Recurrent cutaneous melanoma of the head and neck. Otolaryngol Head Neck Surg 1999;120:391–393.

    PubMed  Google Scholar 

  15. Overgaard J. The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study. Int J Radiat Oncology Biol Phys 1986;12:867–872.

    Article  CAS  Google Scholar 

  16. Dong XD, Tyler D, Johnson JL, DeMatos P, Seigler HF. Analysis of prognosis and disease progression after local recurrences of melanoma. Cancer 2000;88:1063–1071.

    CAS  PubMed  Google Scholar 

  17. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven, 1977.

    Google Scholar 

  18. Cohn-Cedermark G, Mansson-Brahme E, Rutqvist LE, Larsson O, Singnomklao T, Ringborn U. Metastatic patterns, clinical outcome, and malignant phenotype in malignant cutaneous melanoma. Acta Oncol 1999;38:549–557.

    CAS  PubMed  Google Scholar 

  19. Beenken S, Byers R, Smith JL, Goepfert H, Shallenberger R. Desmoplastic melanoma: histologic correlation with behavior and treatment. Arch Otolaryngol Head Neck Surg 1989;115:374–379.

    CAS  PubMed  Google Scholar 

  20. Quinn MJ, Crotty KA, Thompson JF, Coates AS, O’Brien CJ, McCarthy WH. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer 1998;83:1128–1135.

    CAS  PubMed  Google Scholar 

  21. Johanson CR, Harwood AR, Cummings BJ, Quirt I. Radiotherapy in nodular melanoma. Cancer 1983;51:226–232.

    CAS  PubMed  Google Scholar 

  22. Bumeister, Smithers BM, Poulsen M, et al. Radiation therapy for nodal disease in malignant melanoma. World J Surg 1995;19:369–371.

    Google Scholar 

  23. Creagan ET, Cupps RE, Ivins JC, et al. Adjuvant radiation therapy for regional nodal metastases from malignant melanoma: a randomized prospective study. Cancer 1978;42:2206–2210.

    CAS  PubMed  Google Scholar 

  24. Sause WT, Cooper JS, Rush S, et al. Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys 1991;20:429–432.

    CAS  PubMed  Google Scholar 

  25. Mameghan H, Knittle T. Response of melanoma to heat and radiation therapy: a review of the literature and experience from the Prince of Wales Hospital, Sydney. Med J Aust 1988;149:474–481.

    CAS  PubMed  Google Scholar 

  26. Rosenthal MA, Bull CA, Coates AS, et al., Synchronous cisplatinum infusion during radiotherapy in the treatment of metastatic melanoma. Eur J Cancer 1991;27:1564–1566.

    CAS  PubMed  Google Scholar 

  27. Overgaard J, Gonzalez Gonzalez D, Hulshof MC, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 1995;345:540–543.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Section of Surgical Oncology, Oregon Health Sciences University, L223A, 3181 S.W. Sam Jackson Park Rd., Portland, OR, 97201-3098

    Katherine T. Morris MD & John T. Vetto MD

  2. Department of Radiation Oncology, Oregon Health Sciences University, L223A, 3181 S.W. Sam Jackson Park Rd., Portland, OR, 97201-3098

    Carol M. Marquez MD & John M. Holland MD

Authors
  1. Katherine T. Morris MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carol M. Marquez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John M. Holland MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John T. Vetto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morris, K.T., Marquez, C.M., Holland, J.M. et al. Prevention of Local Recurrence After Surgical Debulking of Nodal and Subcutaneous Melanoma Deposits by Hypofractionated Radiation. Ann Surg Oncol 7, 680–684 (2000). https://doi.org/10.1007/s10434-000-0680-y

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10434-000-0680-y

Key Words

Search

Navigation